IMVIGOR

• ClinicalTrials.gov ID: NCT02450331
• Status: Terminated

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection